
global leader diagnost breast imag
surgic product focu women health
diagnost tool
trim pt mainli due gm buy
consist pre-announce deliv good result reiter fy
revenue outlook rais fy ep outlook tax reform guid rev us/
street drive growth intern busi y/i rep
molecular diagnost breast health cynosur q/q despit
four fewer sell day quarter delta y/i expect tax
rate reduc y/i expect reinvest much back
 acceler top line go forward reiter top pick
reiter buy trim pt ep
overal result good rev rep beat
street adj ep beat deliv
segment beat rel model follow breast health cynosur
diagnost off-set shortfal gyn/surg skelet
adj om roughli line
gm due mix adj gm y/i miss due mix
divestitur higher-margin blood screen higher sale lower-margin ou
cyno product lower rev higher margin surgic product
new product breast health breast health rev beat
driven ou breast rev grew y/i nearli
new system sold new lower-end system
system higher-end earli launch sale biopsi system
dispos increas y/i global driver off-set declin
us breast busi encourag expand low end
breast market may help counter concern versu ge
ou molecular diagnost key driver total ou rev
rev grew y/i fxn diagnost revenu beat
street driven molecular dx growth obtain fda approv
hbv assay two week ago import clearanc fortifi virolog launch
cyno slowli bounc back cynosur rev sequenti beat
estim indic easili inning complet
cynosur hire feel good newer leadership divis note
cyno regularli face season headwind march believ new rep hire
launch brand new tempsur envi radio frequenc platform serv
off-set increment posit cyno outlook declin
reiter double-digit growth outlook year segment matter
penetr core market non-cor doc particularli ob/
gyn peg cyno non-cor doctor us alon
guidanc reiter prior revenue guid rep
rais non-gaap ep guid
reflect benefit us tax reform expect tax rate guid
adj ep rev
rep prior midpoint street prior though view
guid conserv model chang next page
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
model slightli trim rev trim adj
ep penni move closer line guid rais
rev y/i carri beat vs
model last quarter given improv outlook cynosur cynosur
segment model revenu y/i compar
street comp last year reiter
adj ep y/i assum lower tax rate partial off-set
view slightli lower gm rel prior forecast rais
revenu estim y/i mainli driven
increas cynosur revenu forecast lower adj ep
y/i y/i mainli driven lower gm forecast despit
full year benefit us tax reform previous larg alreadi model
lower adj gm lower adj gm
larg driven view higher revenu growth lower
buy unchang target price februari
diagnost tool
canaccord genuiti estim compani report
buy unchang target price februari
diagnost tool
canaccord genuiti estim compani report
buy unchang target price februari
diagnost tool
